145 related articles for article (PubMed ID: 15257551)
1. Biotin-rich, optically clear nuclei express estrogen receptor-beta: tumors with morules may develop under the influence of estrogen and aberrant beta-catenin expression.
Nakatani Y; Masudo K; Nozawa A; Inayama Y; Yamanaka S; Ito T; Kitamura H; Notohara K; Kashima K; Yokoyama S; Tsujimoto M; Tamai S; Abe Y; Resl M; Mark EJ
Hum Pathol; 2004 Jul; 35(7):869-74. PubMed ID: 15257551
[TBL] [Abstract][Full Text] [Related]
2. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
3. Aberrant intranuclear localization of biotin, biotin-binding enzymes, and beta-catenin in pregnancy-related endometrium and morule-associated neoplastic lesions.
Gamachi A; Kashima K; Daa T; Nakatani Y; Tsujimoto M; Yokoyama S
Mod Pathol; 2003 Nov; 16(11):1124-31. PubMed ID: 14614052
[TBL] [Abstract][Full Text] [Related]
4. Morules with optically clear nuclei in ovarian borderline endometrioid tumor.
Li CC; Hirokawa M; Qian Z; Fujii Y; Ino H; Wakatsuki S; Horiguchi H; Kagawa N; Sano T
APMIS; 2002 Nov; 110(11):783-8. PubMed ID: 12588418
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.
Chiarelli S; Buriticá C; Litta P; Ciani S; Guarch R; Nogales FF
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4251-6. PubMed ID: 16857799
[TBL] [Abstract][Full Text] [Related]
6. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
Houghton O; Connolly LE; McCluggage WG
Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
[TBL] [Abstract][Full Text] [Related]
7. Morules with biotin-containing optically clear nuclei in colonic tubular adenoma.
Sasaki A; Yokoyama S; Arita T; Inomata M; Kashima K; Nakayama I
Am J Surg Pathol; 1999 Mar; 23(3):336-41. PubMed ID: 10078926
[TBL] [Abstract][Full Text] [Related]
8. Biotin-rich intranuclear inclusions in morule-lacking adenocarcinoma of the gallbladder: a new category of "neoplastic/non-morular" lesions.
Kimura Y; Kashima K; Daa T; Kondo Y; Yada K; Sasaki A; Matsumoto T; Kitano S; Kubo N; Yokoyama S
Virchows Arch; 2005 Feb; 446(2):194-9. PubMed ID: 15647941
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
[TBL] [Abstract][Full Text] [Related]
10. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia.
Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K
APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643
[TBL] [Abstract][Full Text] [Related]
11. Canonical Wnt signaling is critical to estrogen-mediated uterine growth.
Hou X; Tan Y; Li M; Dey SK; Das SK
Mol Endocrinol; 2004 Dec; 18(12):3035-49. PubMed ID: 15358837
[TBL] [Abstract][Full Text] [Related]
12. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma.
Nakatani Y; Miyagi Y; Takemura T; Oka T; Yokoi T; Takagi M; Yokoyama S; Kashima K; Hara K; Yamada T; Nozawa A; Inayama Y; Sakamoto K; Ogawa N; Kitamura H; Resl M; Cho SH; Koss MN; Mark EJ
Am J Surg Pathol; 2004 Jul; 28(7):921-7. PubMed ID: 15223963
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
14. Cribriform-morular variant of papillary thyroid carcinoma. Report of a case showing morules with peculiar nuclear clearing.
Kuma S; Hirokawa M; Xu B; Miyauchi A; Kukudo K; Sano T
Acta Cytol; 2004; 48(3):431-6. PubMed ID: 15192965
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
[TBL] [Abstract][Full Text] [Related]
17. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.
Scholten AN; Creutzberg CL; van den Broek LJ; Noordijk EM; Smit VT
J Pathol; 2003 Nov; 201(3):460-5. PubMed ID: 14595758
[TBL] [Abstract][Full Text] [Related]
18. beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.
Gamallo C; Palacios J; Moreno G; Calvo de Mora J; Suárez A; Armas A
Am J Pathol; 1999 Aug; 155(2):527-36. PubMed ID: 10433945
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas.
Shih HC; Shiozawa T; Miyamoto T; Uchikawa J; Feng Y; Kashima H; Nikaido T; Konishi I
Anticancer Res; 2003; 23(5A):3749-54. PubMed ID: 14666673
[TBL] [Abstract][Full Text] [Related]
20. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
Wappenschmidt B; Wardelmann E; Gehrig A; Schöndorf T; Maass N; Bonatz G; Gassel AM; Pietsch T; Mallmann P; Weber BH; Schmutzler RK
Hum Pathol; 2004 Oct; 35(10):1260-5. PubMed ID: 15492994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
